Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Newpath Partners is a Boston-based venture capital firm founded in 2018, focusing on the life sciences sector. The firm partners with leading academic scientists at the earliest stages of company formation, often before a company formally exists. Their mission is to translate groundbreaking scientific discoveries into transformative therapies that can significantly impact patient care and health outcomes.
As of now, Newpath Partners manages a fund size of $350 million and has launched over 15 portfolio companies since its inception. The firm operates out of Boston, Massachusetts, and aims to align the interests of academic founders with management teams to enhance the performance of its portfolio companies. Newpath Partners is backed by institutional limited partners, ensuring a strong financial foundation for its investments.
Newpath Partners specializes in the life sciences sector, focusing on pre-company creation through growth stages. The firm is particularly interested in regenerative medicine, genomics, oncology, and disruptive therapeutics. High scientific originality is a core criterion in their investment strategy, which emphasizes the potential for groundbreaking treatments and technologies.
The firm typically invests in stages ranging from pre-seed to Series B and growth equity, with check sizes ranging from $1 million to $350 million. Newpath Partners targets innovative companies that can significantly advance healthcare outcomes, aligning with their mission to support transformative therapies.
Newpath Partners has launched over 15 portfolio companies since its inception, showcasing a strong commitment to the life sciences sector. Notable ventures include:
These companies exemplify Newpath's focus on high scientific originality and transformative healthcare solutions.
Dr. Thomas Cahill - Founder of Newpath Partners, Dr. Cahill has extensive experience in the life sciences sector. He has been involved in multiple successful ventures and is known for his expertise in translating scientific discoveries into viable business models.
To pitch Newpath Partners, founders should send an email to info@newpath.partners. It is important to include a comprehensive deck that outlines the business model, scientific innovation, and potential impact on healthcare. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In December 2021, Newpath Partners announced the closing of its second fund, which raised $350 million to support the creation of life sciences companies. The firm aims to target 8-12 additional biotech companies with this fund. Recent coverage in the Boston Globe highlighted Newpath's commitment to backing innovative life sciences ventures.
What are Newpath Partners' investment criteria?
Newpath Partners focuses on life sciences investments, particularly in regenerative medicine, genomics, oncology, and disruptive therapeutics. They prioritize high scientific originality and partner with leading academic scientists at the earliest stages of company formation.
How can I pitch Newpath Partners?
Founders can reach out to Newpath Partners via email at info@newpath.partners. It is advisable to include a detailed overview of the business model, scientific innovation, and potential impact on healthcare outcomes in the pitch.
What stages does Newpath Partners invest in?
The firm invests across various stages, including pre-seed, seed, seed+ (extension), Series A, Series B, and growth equity. This allows them to support companies from inception through to growth phases.
What is the typical check size for investments?
Newpath Partners typically invests between $1 million and $350 million, depending on the stage of the company and the potential for impact in the life sciences sector.
What kind of support do portfolio companies receive?
Newpath Partners provides strategic guidance, operational support, and access to resources that facilitate the translation of scientific innovations into viable business models and therapies. Their deep scientific expertise and strong networks within the academic and biotech communities enhance the value they add to portfolio companies.
What is the geographic focus of Newpath Partners?
The firm primarily focuses on investments within North America, aligning with their mission to support innovative life sciences companies in the region.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.